Orion Capital Management’s Gilead Sciences GILD Stock Holding History

Orion Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,300	Closed	-$77K	–	425
2022 Q1	$77K	Hold	1,300	–	–	0.05%	183
2021 Q4	$94K	Hold	1,300	–	–	0.05%	169
2021 Q3	$91K	Hold	1,300	–	–	0.06%	167
2021 Q2	$90K	Hold	1,300	–	–	0.06%	153
2021 Q1	$84K	Hold	1,300	–	–	0.06%	145
2020 Q4	$76K	Buy	+1,300	New	+$78.4K	0.06%	137

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Orion Capital Management's GILD Position: Q2 2022 in Review

Orion Capital Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 1,300 shares — an estimated $77K sold.

Orion Capital Management first reported a position in GILD in Q4 2020 and held it in 6 quarters. The position peaked at $94K in Q4 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Orion Capital Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
Orion Capital Management sold 1,300 Gilead Sciences shares in Q2 2022, an estimated $77K.
Orion Capital Management first reported a position in Gilead Sciences in Q4 2020 and held it in 6 quarters.
Orion Capital Management's Gilead Sciences position peaked at $94K in Q4 2021.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Orion Capital Management's 13F filing for Q2 2022, filed 22 Jul 2022.